TD Cowen Sticks to Their Buy Rating for ACADIA Pharmaceuticals (ACAD)
TD Cowen Remains a Buy on Pliant Therapeutics (PLRX)
TD Cowen Reaffirms Their Buy Rating on Revolution Medicines (RVMD)
Revolution Medicines Analyst Ratings
Needham Maintains Buy on Revolution Medicines, Raises Price Target to $62
CECO Environmental Analyst Ratings
Truist Lowers Price Target on IRhythm Technologies to $134 From $145, Maintains Buy Rating
Truist Raises Price Target on Integra LifeSciences Holdings to $32 From $25, Maintains Hold Rating
Yelp Analyst Ratings
Owens & Minor Analyst Ratings
Truist Raises Price Target on Glaukos to $141 From $125, Maintains Buy Rating
PubMatic Analyst Ratings
Peloton Interactive Analyst Ratings
Wells Fargo Sticks to Its Buy Rating for Rush Street Interactive (RSI)
Barclays Keeps Their Hold Rating on Werner Enterprises (WERN)
Barclays Remains a Buy on Visteon (VC)
Sprout Social (SPT) Gets a Buy From Barclays
Integra Lifesciences Sell Rating Justified by Production Delays and Overvalued Stock
Analysts Offer Insights on Energy Companies: California Resources Corp (CRC) and Delek US Holdings (DK)
Buy Rating Affirmed for Revolution Medicines on Strong Clinical Data and Favorable Drug Prospect